FDA Leader: We Need To Remove Surprises From Gene Therapy Development
Peter Marks Addresses Commercial And Regulatory Hurdles
Embattled gene therapy companies will take comfort from desire of FDA and EMA help smooth the process of bringing the novel treatments to market.
